Imaging Diagnostic Systems' laser mammogram approved in Australia
This article was originally published in Clinica
Executive Summary
The Australian Therapeutic Goods Administration has approved Imaging Diagnostic Systems' (IDS) CT laser mammography (CTLM) system. It will be distributed in Australia by Jainsons. The CTLM is a noninvasive breast imaging system that uses continuous wave laser technology and patented algorithms to produce 3D images of the breast. It can provide information about blood distribution and new blood vessel formation that is often associated with cancer, and is designed to be used in conjunction with conventional mammography. The device is CE marked for sale in Europe and is approved in Canada. It is not yet available in the US, where IDS (Fort Lauderdale, Florida) is currently carrying out the clinical studies required for a premarket approval (PMA) application.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.